Thrilled to share our new paper comparing different LLMs to extract TNFi reasons and treatment trajectories from UCSF de-identified EHR data with @bmeow19.bsky.social, A. Garcia-Agundez and @jyazdanymd.bsky.social published in JAMIA open. academic.oup.com/jamiaopen/ar... @ucsf-bchsi.bsky.social

Cross-sectional study of adults with SLE in the US estimated 56.3% had polypharmacy (≥5 prescription or OTC meds). Arthritis Care & Research doi.org/10.1002/acr....

🎉 We're honored to present the Evelyn V. Hess Award to Dr. Karen Costenbader for advancing #lupus research and care, and the Mary Betty Stevens Prize to Dr. Andrea Fava for innovative research driving progress in lupus science. Learn more about their research: buff.ly/cn8xViK

Friends today but not tomorrow - come to the #ACR25 Great Debate Monday at 8:30 am on #AI in #Rheumatology!!!

Hey #Rheumsky! We heard you’ve got a conference this weekend! Wishing everyone in Chicago, IL this weekend for #ACR25 a wonderful conference experience! The conference hashtag will send posts directly to the Rheumatology feed, so you won’t miss the action!

@sarahpollet.bsky.social @jyazdanymd.bsky.social @julia-adler-mils.bsky.social @saramurray.bsky.social

Thrilled to see my book on healthcare Al available for preorder! sites.prh.com/preview/6f5c... I tried to cut through the hype, with stories & insights on everything from scribes to surgery, hallucinations to misinformation, med education to regulation. Plus "Will there be doctors?"@portfoliobooks

If the U.S. government wants to save $$$, they should read our article on #biosimilars: link.springer.com/article/10.1...

NEW Episode of the ACR Journals on Air podcast! 🎙️ Epidemiology meets clinical care—Laura Plantinga, PhD, shares insights from her research on #lupus & daily activity limitations 🎧 Listen → acr.tw/4dE1lHe Read the study → doi.org/10.1002/acr.... #Medsky

Miss the conversation on bias in healthcare AI? 🎥 Catch Paige Nong, @ajh.bsky.social, and @ryan-levi.bsky.social as they unpack real-world risks—and what it takes to evaluate AI tools responsibly. See how the experts broke it down: codex.ucsf.edu/events/codex... @tradeoffs.org

Excellent career advice from Peter Hotez journals.plos.org/plosbiology/.... Also some good stuff here for universities to consider in the face of current challenges.

I’m excited to take on this new role and do my small smart to make sure AI is safe, fair, and effective. Best part is getting to work with visionary leaders like @julia-adler-mils.bsky.social @saramurray.bsky.social @sarahpollet.bsky.social and many others

🚨 Big news in AI & healthcare! Jinoos Yazdany, MD, MPH, has been named Executive Director of AI Monitoring in Clinical Care at UCSF. She’ll lead efforts to ensure AI tools are evaluated and deployed safely and effectively. Read more: docit.ucsf.edu/news/jinoos-... @jyazdanymd.bsky.social

I've been waiting for this one!!!

Somewhere in the U.S., there’s a scientist staring at their NSF/NIH grant application wondering why they bother. This post is for you. Science and society both need you. Hang in there and know there is a whole community supporting you.

Fantastic, super clear explanation by Dr. Choo of NIH grants process: takes “tens of thousands of reviewers annually on more than 1000 meetings with study sections like the one I should have been sitting in Thursday.” Even if/when the freeze ends, can’t just be restarted with a snap. 🧪

Health Disparities are real & lethal. Research on ⬇️ health disparities & improving health among impacted pops is critical. The NIMHD (NIH Institute that focuses on ⬇️ disparities) website remains. But if you search NIH Health Disparities, the page is gone. Chilling.

Extremely pleased to see this published! It takes a whole division of rheumatology to be on the look out for active SLE patients in the clinics/hospital with an active flare to enroll them in research and follow them over time clinicalepigeneticsjournal.biomedcentral.com/articles/10....

We have 2 fellowship positions available (1 pediatric rheumatology, 1 med-peds rheumatology) at the Children’s Hospital at Montefiore, Bronx, NY. We welcome #IMG and sponsor both J1 and H1b visas. You will never regret being part of this outstanding team! See information below if interested!

Dr. Jenny Mandal's Rheumatology Access Expansion (RAE: raeinitiative.org) has trained 111 primary care clinicians on Native American reservations around the U.S. to care for people with #RA. Read about her inspiring work at the link below. #rheumsky #UCSFrheum

This trial is very interesting - we need ways to prevent LN before it happens! Early MMF helps but for how long should rx continue? Also need to further define who will benefit. jamanetwork.com/journals/jam...

#ACR24 Older patients, those in low nSES areas, and certain racial/ethnic groups less likely to get b/tsDMARDs, trends that did not change over last decade.#RISE-registry. www.heal.com/news/rheumat...

For the second year, @ACRheum’s Global Engagement Committee along with @rheum_covid leaders were able to review over 60 applications and provide travel awards to these accomplished individuals to attend #ACR24

And I found this old tweet from @philipcrobinson from the first @ACRheum I attended in 2016, and it reminds me of why we do what we do, and what this program is about @jyazdanymd.bsky.social @profbeckyg.bsky.social @nicoladalbeth.bsky.social

Thank you to all the people who worked over many months to put on #ACR24. Exciting to witness the renaissance of cellular therapies for #rheumatic diseases and fun to catch up with old friends. See you next year!

#ACR24 lupus nephritis guideline puts nickel down on choosing CNI if proteinuria >3 grams based on post-hoc analysis of BLISS-LN. Hopefully a head-to-head comparison of adding BEL or CNI or OBI will happen at some point

We are going to ferry all the rheumatologists over to bluesky 💜 @jyazdanymd.bsky.social #ACR24

Congratulations Brad and Ali on your #LFA awards at #ACR24. Two amazing lupus researchers.

Woah! Patient got pregnant (I think couple months) after CAR-T therapy. Mom and baby did ok. Baby had normal CD19 numbers. #ACR24 #SLE

Plenary 2: Dr. Schmajuk shows that #RISE-registry data results in improvements in performance on several quality measures before and after joining registry in interrupted time series analysis. #ACR24.

Plenary 2 #ACR24 Fava presenting 14 biomarker #LN panel that predicts histology, outperforms traditional biomarkers like dsdna, complement, proteinuria. Persistent elevation of biomarker predicts renal decline. Promising!

Looking to gather a list of all rheumatologists and rheumatology professionals! Comment if I missed you! #ACR24 #rheum go.bsky.app/CEj2dcZ

Discussing bringing more #AI tools @ACRheum #RISE-registry - so exciting to envision the registry of our future! #ACR24

Hello #ACR24!